Proprietary Technology for Precision Modelling




Innovative algorithms and modelling frameworks developed to transform biomedical data into powerful predictive tools

Tools
    
Models
    
SaaS



At the core of Bioenhancer Systems is a proprietary AutoML engine designed to generate bespoke predictive models that deliver high performance with minimal biomarker complexity.

This adaptive algorithm accelerates model development across diverse biological domains, enabling fast, interpretable, and scalable outcomes.

Our technology portfolio also includes kinetic models based on ordinary differential equations (ODEs), network-based frameworks, and scoring-driven machine learning models β€” all validated in real-world applications including cancer prognosis, disease classification, and viral transmission prediction.

In addition, we have developed specialised bioinformatics tools such as MSDanaliser and ROCplot, designed to support model evaluation through intuitive visualisation and performance interpretation.




Why choose our technology?

  • Faster development cycles using our proprietary AutoML engine.

  • High accuracy with fewer biomarkers, reducing validation and testing complexity.

  • Flexible modelling frameworks including ODEs, networks, and scoring-based ML.

  • Interpretable and transparent outputs for regulatory and scientific use.

  • Easy integration via APIs, dashboards, or hosted tools.

  • Validated across domains, including cancer, COVID-19, and omics research.

  • Flexible engagement β€” from licensing our platform to co-developing new tools.





  • Powering Innovation with a Modern Scientific Tech Stack











    Selected Publications


  • Exploring AI-Driven Machine Learning Approaches for Optimal Classification of Peri-Implantitis Based on Oral Microbiome Data: A Feasibility Study
  • Diagnostics 2025 πŸ”—

  • Facilitating β€œOmics” for Phenotype Classification Using a User-Friendly AI-Driven Platform: Application in Cancer Prognostics
  • BioMedInformatics 2023 πŸ”—

  • Predicting Cancer Prognostics from Tumour Transcriptomics Using an Auto Machine Learning Approach
  • Medical Sciences Forum 2023 πŸ”—





    Empowering Biotech and Biomedical Research instituitions with state-of-the-art predictive modelling and bioinformatics solutions.